Literature DB >> 16754762

Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders.

Linda S Grossman1, Martin Harrow, Cherise Rosen, Robert Faull.   

Abstract

OBJECTIVE: It is generally believed by the field of psychiatry that women with schizophrenia have better outcomes and higher rates of recovery than their male counterparts, because many studies on the topic support this finding. Fewer data are available to assess potential sex differences among individuals with other psychotic disorders. This study used longitudinal data on sex differences previously unavailable to the field to examine long-term global outcome, potential recovery, course of illness, and rehospitalization for schizophrenia, other psychotic disorders, and nonpsychotic disorders.
METHODS: A total of 239 young psychiatric patients (mean age of 23.4 years) were assessed prospectively at the index hospitalization and then followed over 15 years at five follow-up points (at a mean of two, 4.5, 7.5, ten, and 15 years). The sample consisted of 69 patients with schizophrenia, 56 with other psychotic diagnoses, and 114 with nonpsychotic psychiatric disorders.
RESULTS: Sex differences in outcome were found for both patients with schizophrenia and those with other psychotic disorders, with women consistently showing better functioning over time, more frequent periods of good functioning and periods of recovery, less likelihood of uniformly poor outcome, and fewer and shorter rehospitalizations. Unlike both groups of patients who were psychotic, the patients with nonpsychotic disorders showed no significant sex differences in outcome.
CONCLUSIONS: Both longitudinally and at each individual follow-up point, the data suggest that women with schizophrenia and with other types of psychotic disorders generally show better outcome than men with similar diagnoses. The sex differences in outcome for patients with schizophrenia were consistent over time. However, these sex differences were only moderate in size compared with the much larger difference in outcome between the diagnostic groups. The longitudinal data add a new dimension to previous research and suggest that sex differences in outcome are not specific to patients with schizophrenia but rather occur among patients with psychotic disorders in general.

Entities:  

Mesh:

Year:  2006        PMID: 16754762     DOI: 10.1176/ps.2006.57.6.844

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  23 in total

1.  Antecedents and patterns of suicide behavior in first-admission psychosis.

Authors:  Shelly Bakst; Jonathan Rabinowitz; Evelyn J Bromet
Journal:  Schizophr Bull       Date:  2009-03-09       Impact factor: 9.306

2.  Heat shock protein 70 gene polymorphisms are associated with paranoid schizophrenia in the Polish population.

Authors:  Malgorzata Kowalczyk; Aleksander Owczarek; Renata Suchanek; Monika Paul-Samojedny; Anna Fila-Danilow; Paulina Borkowska; Krzysztof Kucia; Jan Kowalski
Journal:  Cell Stress Chaperones       Date:  2013-07-28       Impact factor: 3.667

3.  Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder.

Authors:  Rachael K Willhite; Tara A Niendam; Carrie E Bearden; Jamie Zinberg; Mary P O'Brien; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2008-06-24       Impact factor: 4.939

4.  Where have all the women gone?: participant gender in epidemiological and non-epidemiological research of schizophrenia.

Authors:  Julia Longenecker; Jamie Genderson; Dwight Dickinson; James Malley; Brita Elvevåg; Daniel R Weinberger; James Gold
Journal:  Schizophr Res       Date:  2010-06       Impact factor: 4.939

5.  Age, sex and first treatment of schizophrenia in a population cohort.

Authors:  K Kleinhaus; S Harlap; M Perrin; O Manor; M Weiser; P Lichtenberg; D Malaspina
Journal:  J Psychiatr Res       Date:  2010-06-11       Impact factor: 4.791

Review 6.  Sex steroids and schizophrenia.

Authors:  Julie A Markham
Journal:  Rev Endocr Metab Disord       Date:  2012-09       Impact factor: 6.514

7.  Reducing emergency medical service use in patients with chronic psychotic disorders: results from the FAST intervention study.

Authors:  Brent T Mausbach; Veronica Cardenas; Christine L McKibbin; Dilip V Jeste; Thomas L Patterson
Journal:  Behav Res Ther       Date:  2007-10-07

8.  Source-based morphometry of gray matter volume in men with first-episode schizophrenia.

Authors:  Tomás Kaspárek; Radek Marecek; Daniel Schwarz; Radovan Prikryl; Jirí Vanícek; Michal Mikl; Eva Cesková
Journal:  Hum Brain Mapp       Date:  2010-02       Impact factor: 5.038

9.  Locus of control: relation to schizophrenia, to recovery, and to depression and psychosis -- A 15-year longitudinal study.

Authors:  Martin Harrow; Barry G Hansford; Ellen B Astrachan-Fletcher
Journal:  Psychiatry Res       Date:  2009-07-01       Impact factor: 3.222

Review 10.  Emotional response deficits in schizophrenia: insights from affective science.

Authors:  Ann M Kring; Erin K Moran
Journal:  Schizophr Bull       Date:  2008-06-25       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.